Synopsys, Inc. $SNPS Shares Acquired by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 107.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,562 shares of the semiconductor company’s stock after buying an additional 15,837 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in Synopsys were worth $12,117,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Sankala Group LLC bought a new position in shares of Synopsys during the 4th quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys during the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys during the fourth quarter worth approximately $28,000. Atlas Capital Advisors Inc. acquired a new position in Synopsys in the fourth quarter worth approximately $32,000. Finally, Osbon Capital Management LLC acquired a new position in Synopsys in the fourth quarter worth approximately $34,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently commented on SNPS. Stifel Nicolaus increased their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Bank of America boosted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Citigroup lifted their price target on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Robert W. Baird set a $558.00 price objective on Synopsys in a report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $570.06.

Read Our Latest Stock Analysis on SNPS

Insider Activity

In related news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.

Synopsys Stock Up 0.5%

Shares of SNPS traded up $2.13 during mid-day trading on Friday, reaching $445.50. The company’s stock had a trading volume of 839,512 shares, compared to its average volume of 1,858,163. The business has a fifty day moving average of $477.80 and a 200 day moving average of $460.71. The company has a market cap of $85.30 billion, a price-to-earnings ratio of 103.12, a price-to-earnings-growth ratio of 2.62 and a beta of 1.22. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.